Back to Journals » Integrated Blood Pressure Control » Volume 2 » default
Integrated Blood Pressure Control
ISSN: 1178-7104
- View all (152)
- Volume 16, 2023 (6)
- Volume 15, 2022 (10)
- Volume 14, 2021 (19)
- Volume 13, 2020 (19)
- Volume 12, 2019 (5)
- Volume 11, 2018 (10)
- Volume 10, 2017 (6)
- Volume 9, 2016 (10)
- Volume 8, 2015 (7)
- Volume 7, 2014 (8)
- Volume 6, 2013 (15)
- Volume 5, 2012 (4)
- Volume 4, 2011 (8)
- Volume 3, 2010 (17)
- Volume 2, 2009 (5)
- Volume 1, 2008 (3)
Archive: Volume 2, 2009

Current concepts in combination therapy for the treatment of hypertension: combined calcium channel blockers and RAAS inhibitors
Alberto F Rubio-Guerra, David Castro-Serna, Cesar I Elizalde Barrera, et al
Integrated Blood Pressure Control 2009, 2:55-62
Published Date: 23 November 2009

Valsartan combination therapy in the management of hypertension – patient perspectives and clinical utility
David T Nash, Michael S McNamara
Integrated Blood Pressure Control 2009, 2:39-54
Published Date: 28 October 2009

Can nocturnal hypertension predict cardiovascular risk?
Oded Friedman, Alexander G Logan
Integrated Blood Pressure Control 2009, 2:25-37
Published Date: 4 September 2009

Clinical approach in treatment of resistant hypertension
Jennifer Frank, David Sommerfeld
Integrated Blood Pressure Control 2009, 2:9-23
Published Date: 30 July 2009

Effects of antihypertensive drugs on carotid intima-media thickness: Focus on angiotensin II receptor blockers. A review of randomized, controlled trials
Cesare Cuspidi, Francesca Negri, Valentina Giudici, Anna Capra, et al.
Integrated Blood Pressure Control 2009, 2:1-8
Published Date: 26 June 2009